An educational resource from MD Anderson helps patients understand mismatch repair deficiency and proficiency, key biomarkers that guide immunotherapy decisions. (UT MD Anderson Cancer Center)
MD Anderson explains DNA mismatch repair status for patients
The CRC Digest